These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 25995185)
1. The prognostic value of regadenoson stress: Has the case been made? Doukky R J Nucl Cardiol; 2015 Aug; 22(4):608-10. PubMed ID: 25995185 [No Abstract] [Full Text] [Related]
2. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. Farzaneh-Far A; Shaw LK; Dunning A; Oldan JD; O'Connor CM; Borges-Neto S J Nucl Cardiol; 2015 Aug; 22(4):600-7. PubMed ID: 25987234 [TBL] [Abstract][Full Text] [Related]
3. Application of inverse probability weights in survival analysis. Wang G; Aban I J Nucl Cardiol; 2015 Aug; 22(4):611-3. PubMed ID: 26021479 [No Abstract] [Full Text] [Related]
4. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. Doukky R; Fughhi I; Campagnoli T; Wassouf M; Ali A J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040 [TBL] [Abstract][Full Text] [Related]
6. Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients. El-Hajj S; AlJaroudi WA; Farag A; Bleich S; Manaoragada P; Iskandrian AE; Hage FG J Nucl Cardiol; 2016 Feb; 23(1):101-12. PubMed ID: 26017713 [TBL] [Abstract][Full Text] [Related]
7. Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping. van Dijk R; Kuijpers D; Kaandorp TAM; van Dijkman PRM; Vliegenthart R; van der Harst P; Oudkerk M Int J Cardiovasc Imaging; 2017 Nov; 33(11):1753-1759. PubMed ID: 28547666 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. AlJaroudi W; Campagnoli T; Fughhi I; Wassouf M; Ali A; Doukky R J Nucl Cardiol; 2016 Jun; 23(3):560-9. PubMed ID: 26293358 [TBL] [Abstract][Full Text] [Related]
9. Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials. Mahmarian JJ; Peterson LE; Xu J; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Nabi F J Nucl Cardiol; 2015 Apr; 22(2):248-61. PubMed ID: 25287737 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Myocardial Perfusion Analysis in Patients with Coronary Artery Disease: A Meta-Analysis. Xiu J; Cui K; Wang Y; Zheng H; Chen G; Feng Q; Bin J; Wu J; Porter TR J Am Soc Echocardiogr; 2017 Mar; 30(3):270-281. PubMed ID: 28049598 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Stress Dynamic Myocardial Perfusion CT in a Multicenter Population With Known or Suspected Coronary Artery Disease. Meinel FG; Pugliese F; Schoepf UJ; Ebersberger U; Wichmann JL; Lo GG; Choe YH; Wang Y; Segreto S; Bamberg F; De Cecco CN AJR Am J Roentgenol; 2017 Apr; 208(4):761-769. PubMed ID: 28177653 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching. Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068 [TBL] [Abstract][Full Text] [Related]
13. The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol. Thomas GS; Cullom SJ; Kitt TM; Feaheny KM; Ananthasubramaniam K; Gropler RJ; Jain D; Thompson RC J Nucl Cardiol; 2017 Jun; 24(3):788-802. PubMed ID: 28224449 [TBL] [Abstract][Full Text] [Related]
14. Adenosine triphosphate stress myocardial perfusion imaging for risk stratification of patients aged 70 years and older with suspected coronary artery disease. Yao Z; Zhu H; Li W; Chen C; Wang H; Shi L; Zhang W J Nucl Cardiol; 2017 Apr; 24(2):429-433. PubMed ID: 26797919 [TBL] [Abstract][Full Text] [Related]
15. Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease. Kero T; Saraste A; Lagerqvist B; Sörensen J; Pikkarainen E; Lubberink M; Knuuti J J Nucl Cardiol; 2022 Feb; 29(1):24-36. PubMed ID: 34386859 [TBL] [Abstract][Full Text] [Related]
17. Regadenoson Stress Real-Time Myocardial Perfusion Echocardiography for Detection of Coronary Artery Disease: Feasibility and Accuracy of Two Different Ultrasound Contrast Agents. Abdelmoneim SS; Mulvagh SL; Xie F; O'Leary E; Adolphson M; Omer MA; Nhola LF; Huang R; Warta SJ; Kirby B; Porter TR J Am Soc Echocardiogr; 2015 Dec; 28(12):1393-400. PubMed ID: 26416199 [TBL] [Abstract][Full Text] [Related]
18. Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases. Reyes E; Richard Underwood S J Nucl Cardiol; 2020 Feb; 27(1):315-321. PubMed ID: 31797320 [TBL] [Abstract][Full Text] [Related]
19. Performance and safety profile of regadenoson myocardial perfusion imaging: first experience in Greece. Koutsikos J; Angelidis G; Zafeirakis A; Mamarelis I; Vogiatzis M; Ilia E; Lazaridis K; Demakopoulos N Hell J Nucl Med; 2017; 20(3):232-236. PubMed ID: 29177261 [TBL] [Abstract][Full Text] [Related]
20. Regadenoson for myocardial perfusion imaging: Is it safe? Hage FG J Nucl Cardiol; 2014 Oct; 21(5):871-6. PubMed ID: 24939324 [No Abstract] [Full Text] [Related] [Next] [New Search]